檢索結果 - Alison M. Schram

Refine Results
  1. 1
    How I treat hemophagocytic lymphohistiocytosis in the adult patient

    How I treat hemophagocytic lymphohistiocytosis in the adult patient 由 Alison M. Schram, Nancy Berliner

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology

    Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology 由 Jessica J. Tao, Alison M. Schram, David M. Hyman

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

    Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance 由 Alison M. Schram, Matthew T. Chang, Philip Jonsson, Alexander Drilon

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Toward a More Precise Future for Oncology

    Toward a More Precise Future for Oncology 由 Yonina R. Murciano‐Goroff, Barry S. Taylor, David M. Hyman, Alison M. Schram

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Discovery through clinical sequencing in oncology

    Discovery through clinical sequencing in oncology 由 Mark T.A. Donoghue, Alison M. Schram, David M. Hyman, Barry S. Taylor

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Marked hyperferritinemia does not predict for HLH in the adult population

    Marked hyperferritinemia does not predict for HLH in the adult population 由 Alison M. Schram, Federico Campigotto, Ann Mullally, Annemarie E. Fogerty, Elena Massarotti, Donna Neuberg, Nancy Berliner

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years

    Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years 由 Alison M. Schram, Paige Comstock, Meghan Campo, Daniel Gorovets, Ann Mullally, Kelly Bodio, Jon Arnason, Nancy Berliner

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

    A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours 由 Alison M. Schram, Leena Gandhi, Monica Mita, Lars Damstrup, Frank Campana, Manuel Hidalgo, Enrique Grande, David M. Hyman, Rebecca S. Heist

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The activity, safety, and evolving role of brigatinib in patients with <em>ALK</em>-rearranged non-small cell lung cancers

    The activity, safety, and evolving role of brigatinib in patients with <em>ALK</em>-rearranged non-small cell lung cancers 由 Joshua K. Sabari, Fernando C. Santini, Alison M. Schram, Isabella Bergagnini, Ruqin Chen, Chebli Mrad, W. Victoria Lai, Kathryn C. Arbour, Alexander Drilon

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Impact of Data Presentation on Physician Performance Utilizing Artificial Intelligence-Based Computer-Aided Diagnosis and Decision Support Systems

    Impact of Data Presentation on Physician Performance Utilizing Artificial Intelligence-Based Computer-Aided Diagnosis and Decision Support Systems 由 Lev Barinov, Ajit Jairaj, Murray Becker, Samantha Seymour, Edward S. Lee, Alison M. Schram, E. W. Lane, Alberto F. Goldszal, David A. Quigley, Lina Paster

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations

    TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations 由 Ezra Rosen, Debra A. Goldman, Jaclyn F. Hechtman, Ryma Benayed, Alison M. Schram, Emiliano Cocco, Sophie Shifman, Yixiao Gong, Ritika Kundra, James P. Solomon, Alberto Bardelli, Maurizio Scaltriti, Alexander Drilon, Alexia Iasonos, Barry S. Taylor, David M. Hyman

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations

    Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations 由 Timothy A. Yap, Seock‐Ah Im, Alison M. Schram, Adam Sharp, Judith Balmañà, Richard D. Baird, Jessica Brown, Maria Schwaederlé, Elizabeth A. Pilling, Ganesh Moorthy, Spiros Linardopoulos, Adam Dowson, Carol Pound, Edit Lukacs, Sabina Cosulich, Stephen J. Luen

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms

    A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms 由 Outi Kilpivaara, Semanti Mukherjee, Alison M. Schram, Martha Wadleigh, Ann Mullally, Benjamin L. Ebert, Adam J. Bass, Sachie Marubayashi, Adriana Heguy, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Kenneth Offit, Richard M. Stone, D. Gary Gilliland, Robert J. Klein, Ross L. Levine

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes

    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes 由 Maria I. Carlo, Joshua Chaim, Sujata Patil, Yelena Kemel, Alison M. Schram, Kaitlin M. Woo, Devyn Taylor Coskey, Gouri J. Nanjangud, Martin H. Voss, Darren R. Feldman, James J. Hsieh, A. Ari Hakimi, Ying‐Bei Chen, Robert J. Motzer, Chung‐Han Lee

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions

    Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions 由 Emiliano Cocco, Jamal Benhamida, Sumit Middha, Ahmet Zehir, Kerry Mullaney, Jinru Shia, Rona Yaeger, Liying Zhang, Donna Wong, Liliana Villafania, Khédoudja Nafa, Maurizio Scaltriti, Alexander Drilon, Leonard B. Saltz, Alison M. Schram, Zsofia K. Stadler, David M. Hyman, Ryma Benayed, Marc Ladanyi, Jaclyn F. Hechtman

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

    High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden 由 Ryma Benayed, Michael Offin, Kerry Mullaney, Purvil Sukhadia, Kelly Rios, Patrice Desmeules, Ryan Ptashkin, Helen Won, Jason C. Chang, Darragh Halpenny, Alison M. Schram, Charles M. Rudin, David M. Hyman, Maria E. Arcila, Michael F. Berger, Ahmet Zehir, Mark G. Kris, Alexander Drilon, Marc Ladanyi

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions

    The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions 由 Dong‐Wan Kim, Alison M. Schram, Antoine Hollebecque, Kazumi Nishino, Teresa Macarulla, Sun Young Rha, M. Duruisseaux, Stephen V. Liu, Mohammed Najeeb Al Hallak, Kumiko Umemoto, Claas Wesseler, James M. Cleary, Christoph Springfeld, Cindy Neuzillet, Andrew K. Joe, Shekeab Jauhari, Jim Ford, Kōichi Goto

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Genome doubling shapes the evolution and prognosis of advanced cancers

    Genome doubling shapes the evolution and prognosis of advanced cancers 由 Craig M. Bielski, Ahmet Zehir, Alexander Penson, Mark T.A. Donoghue, Walid K. Chatila, Joshua Armenia, Matthew T. Chang, Alison M. Schram, Philip Jonsson, Chaitanya Bandlamudi, Pedram Razavi, Gopa Iyer, Mark E. Robson, Zsofia K. Stadler, Nikolaus Schultz, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Barry S. Taylor

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer

    Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer 由 Craig M. Bielski, Mark T.A. Donoghue, Mayur Gadiya, Aphrothiti J. Hanrahan, Helen Won, Matthew T. Chang, Philip Jonsson, Alexander Penson, Alexander N. Gorelick, Christopher Harris, Alison M. Schram, Aijazuddin Syed, Ahmet Zehir, Paul B. Chapman, David M. Hyman, David B. Solit, Kevin Shannon, Sarat Chandarlapaty, Michael F. Berger, Barry S. Taylor

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors

    Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors 由 Timothy A. Yap, Aditya Bardia, Michael Dvorkin, Matthew D. Galsky, J. Thaddeus Beck, David R. Wise, O. B. Karyakin, Gábor Rubovszky, Nikolay Kislov, Kristoffer Staal Rohrberg, Anil A. Joy, Melinda L. Telli, Alison M. Schram, Umberto Conte, Colombe Chappey, Ross Stewart, Daria Stypinski, Elisabete Michelon, Rossano Cesari, Panagiotis A. Konstantinopoulos

    出版 2022
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:

檢索工具: